Warren Buffett’s investment principle emphasizes caution in times of greed and opportunism during fear. Recently, shares of Greenwich LifeSciences Inc (GLSI) reached an oversold status, with a Relative Strength Index (RSI) of 29.9, indicating a potential buying opportunity. The stock traded as low as $15.55 on Friday, significantly below its 52-week high of $34.10.
As context, the S&P 500 ETF (SPY) has a current RSI of 45.5, suggesting that GLSI may have experienced heavy selling, which could be reaching its limit. GLSI’s 52-week performance shows a low point of $7.78 and a recent last trade of $16.32.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
